查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654685

全球静脉留置针市场 - 2025 至 2033 年

Global IV Cannula Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球静脉留置针市场规模达到 4,590 万美元，预计到 2033 年将达到 7,470 万美元，2025-2033 年预测期间的复合年增长率为 5.6%。

静脉插管（IV 插管）是一种医疗设备，用于进入患者的静脉注射液体、药物或抽血。它是一种细小而柔软的管子，通常透过针头插入静脉，然后拔出针头，留下套管以便继续进行操作。它专为短期至中期使用而设计，必须小心处理以防止併发症。

由于慢性病发病率不断上升、外科手术增多、医疗保健基础设施的进步以及家庭医疗保健服务的不断扩大等多种因素，静脉留置针市场正在稳步增长。由于许多患者现在在家中接受抗生素、化疗或补液疗法等治疗，因此向家庭医疗保健和门诊护理的转变增加了对静脉插管的需求。这导致对易于使用、安全且可靠的静脉输液系统的需求增加。例如，美国临床肿瘤学会 (ASCO) 报告称，美国每年诊断出超过 180 万例新癌症病例，其中许多患者需要在家中进行静脉化疗输液，这导致家庭医疗保健对静脉插管的需求不断增加。

市场动态：

驱动因素与约束因素

外科手术数量不断增加

外科手术数量的增加极大地推动了静脉插管市场的成长，预计将在预测期内推动市场的发展。它们的主要用途是在手术期间提供液体管理、药物输送、麻醉和输血。随着医疗技术的进步，全球选择性手术和紧急手术的数量增加。这些程序需要透过静脉注射来实现各种目的，例如麻醉、液体管理和药物管理。

例如，根据美国国立卫生研究院（NIH）的数据，全球每年进行超过 3.1 亿例大型手术，其中美国进行约 4,000 万至 5,000 万例手术，欧洲进行 2,000 万例手术。外科手术数量的不断增加凸显了医院和外科中心对静脉插管的持续需求。

心臟外科手术、肿瘤外科手术、骨科手术、整形外科手术和神经外科手术等外科专业的日益增多，需要专门的静脉输液通路设备，包括具有安全系统或用于精细手术的小型仪表等先进功能的设备。例如，根据国际美容整形外科学会（ISAPS）的数据，外科手术数量增加了5.5%，整形外科医生进行了超过1580万例手术，并进行了1910万例非手术手术。过去四年，整体成长率为40%。整形手术的兴起增加了静脉插管的需求。

感染和併发症的风险

使用静脉插管相关的感染和併发症风险是阻碍静脉插管市场成长的重要因素。感染和其他併发症会导致严重的健康问题、延长住院时间并增加医疗费用，从而降低患者满意度并削弱静脉注射疗法的有效性。

使用静脉插管的主要问题之一是医院获得性感染 (HAI) 的风险，尤其是血流感染 (BSI) 和局部感染。这些感染通常是由于插入不当、缺乏卫生或长时间使用套管引起的，从而导致静脉炎或败血症等併发症。

例如，根据医疗保健研究和品质机构的数据，中心静脉导管相关血流感染 (CLABSI) 是最常见的 HAI 类型之一，美国每年报告约 28,000 例。

由于套管针引起的刺激而引起的静脉发炎会导致疼痛、肿胀，有时还会导致感染。渗透，即静脉输液洩漏到周围组织而不是进入血液，是另一个严重的併发症。医护人员在插入、操作或拔出静脉插管时有遭受针刺伤的风险，尤其是在高风险环境中。这些伤害可能导致接触爱滋病毒、B型肝炎和C型肝炎等血源性病原体。

例如，根据美国疾病管制与预防中心 (CDC) 的数据，美国医院每年约有 385,000 起针刺伤和其他锐器相关伤害，其中许多涉及静脉插管。这引发了人们对医护人员和病人安全的担忧，影响了对具有内置保护功能的更安全的静脉插管的需求。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 按规格大小截取的片段
  • 材料片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 外科手术数量不断增加
    • 限制
      • 感染和併发症的风险
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：静脉留置针市场（依产品类型）

  • 週边静脉插管
  • 中心静脉插管
  • 引流管

第 6 章：静脉留置针市场（依规格尺寸）

  • 14G
  • 16G
  • 17G
  • 18G
  • 20G
  • 22克
  • 24G
  • 26克

第 7 章：静脉留置针市场（依材料）

  • 聚氨酯
  • 特氟龙（聚四氟乙烯 (PTFE)）
  • 硅酮
  • PVC（聚氯乙烯）
  • 其他的

第 8 章：静脉留置针市场（依应用）

  • 输血
  • 药品管理局
  • 外科手术
  • 诊断程序
  • 其他的

第 9 章：静脉留置针市场（依最终用户划分）

  • 医院
  • 专科诊所
  • 家庭护理设置
  • 其他的

第 10 章：静脉注射插管市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 12 章：公司简介

  • Becton, Dickinson and Company
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • Nipro Corporation
  • Romsons Scientific & Surgical Pvt. Ltd.
  • Medtronic plc
  • Cruzine
  • MRK Healthcare Pvt. Ltd.
  • Bio Med Healthcare Products Pvt Ltd
  • AdvaCare Pharma
  • iLife Medical Devices Pvt Ltd
  • Neotec Medical

第 13 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 14 章：附录

简介目录
Product Code: MDP9129

The global IV cannula market reached US$ 45.9 million in 2024 and is expected to reach US$ 74.7 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

An IV cannula, also known as an intravenous cannula, is a medical device used to provide access to a patient's vein for the purpose of administering fluids, medications or drawing blood. It is a small, flexible tube typically inserted into the vein through a needle, which is then removed, leaving the cannula in place to allow ongoing access. It is designed for short- to medium-term use and must be handled with care to prevent complications.

The IV cannula market is growing steadily due to various factors such as the increasing prevalence of chronic diseases, rising surgical procedures, advancements in healthcare infrastructure and expanding home healthcare services. The shift towards home healthcare and outpatient care has increased the demand for IV cannulas, as many patients now receive treatments like antibiotics, chemotherapy, or hydration therapy at home. This has led to a rise in demand for easy-to-use, safe, and reliable IV access systems. For instance, the American Society of Clinical Oncology (ASCO) reports that over 1.8 million new cancer cases are diagnosed annually in the U.S., and many of these patients will require home-based IV chemotherapy infusions, contributing to the rising demand for IV cannulas in home healthcare.

Market Dynamics: Drivers & Restraints

Rising number of surgical procedures

The rising number of surgical procedures is significantly driving the growth of the IV cannula market and is expected to drive the market over the forecast period. Their primary use is for providing fluid administration, medication delivery, anesthesia, and blood transfusion during surgeries. With advancements in medical technology, the global number of both elective and emergency surgeries has increased. These procedures require IV access for various purposes such as anesthesia, fluid management, and medication administration.

For instance, according to the National Institute of Health (NIH), globally, over 310 million major surgeries are performed every year, in this, around 40 to 50 million surgeries are performed in USA and 20 million surgeries are performed in Europe. This rising number of surgical procedures highlights a continuous demand for IV cannulas in hospitals and surgical centers.

The rise in the variety of surgical specialties such as cardiac surgeries, oncological surgeries, orthopedic surgeries, plastic surgeries and neurosurgeries necessitates specialized IV access devices, including those with advanced features like safety systems or small gauges for delicate procedures. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons and 19.1 non-surgical procedures. Over the last four years, the overall increase is 40%. This rising plastic surgeries boosts the demand for IV cannulas.

Risk of infections and complications

The risk of infections and complications associated with the use of IV cannulas is a significant factor hampering the growth of the IV cannula market. Infections and other complications can lead to severe health issues, prolonged hospital stays, and increased medical costs, which can reduce patient satisfaction and undermine the effectiveness of IV therapies.

One of the major concerns with IV cannula use is the risk of hospital-acquired infections (HAIs), particularly bloodstream infections (BSIs) and local site infections. These infections are typically caused by improper insertion, lack of hygiene or prolonged use of the cannula, leading to complications such as phlebitis or sepsis.

For instance, according to Agency for Healthcare Research and Quality, central-line-associated bloodstream infections (CLABSIs) are among the most common types of HAIs, with approximately 28,000 cases reported annually in the U.S. These infections can result from the use of intravenous catheters, contributing to the hesitancy in using IV cannulas and slowing market growth.

Inflammation of the vein due to irritation caused by the cannula can lead to pain, swelling, and sometimes infection. Infiltration, where the IV fluid leaks into the surrounding tissue instead of entering the bloodstream, is another significant complication. Healthcare workers are at risk of needle-stick injuries when inserting, manipulating, or removing IV cannulas, especially in high-risk environments. These injuries can lead to exposure to bloodborne pathogens such as HIV, Hepatitis B and Hepatitis C.

For instance, according to Centers for Disease Control and Prevention (CDC), approximately 385,000 needle-stick injuries and other sharps-related injuries occur annually in U.S. hospitals, many involving IV cannulas. This raises concerns about the safety of healthcare workers and patients, influencing the demand for safer IV cannulas with built-in protective features.

Segment Analysis

The global IV cannula market is segmented based on product type, gauge size, material, application, end-user and region.

Product Type:

The peripheral IV cannula segment is expected to dominate the IV cannula market share

Peripheral IV cannulas are primarily used for fluid infusion, medication administration, blood transfusions and anesthesia in patients requiring short-term intravenous access. They are particularly common in emergency departments, pediatric care and surgical units. For instance, the American Society of Anesthesiologists (ASA) reports that over 40 to 50 million surgeries are performed annually in the U.S., with peripheral IV cannulas being used in a majority of these procedures for anesthesia and fluid administration.

Peripheral IV cannulas are typically used for short-term intravenous access (generally up to 72 hours) and can be quickly inserted into peripheral veins, such as those in the arm, hand, or forearm. The ease of insertion makes them ideal for emergency situations and routine clinical procedures. According to a study in the Journal of Infusion Nursing, peripheral IV cannulas are used in approximately 75-80% of all hospital admissions for intravenous therapy, largely due to their simplicity, speed, and effectiveness.

Geographical Analysis

North America is expected to hold a significant position in the IV cannula market share

The high prevalence of surgeries in North America, driven by the aging population and the widespread use of medical technologies, directly boosts the demand for IV cannulas. These procedures require intravenous access for medications, fluids, and anesthesia. The National Institute of Health (NIH) reports that more than 40 million surgeries are performed annually in the U.S., most of which involve the use of IV cannulas for intravenous access during procedures.

In North America, there is a growing focus on patient safety and the prevention of healthcare-associated infections (HAIs), which drives demand for safer IV cannulas. This includes the adoption of safety features in IV cannulas, such as shielded needles, antimicrobial coatings and advanced insertion technology. The demand for safer IV cannulas in North America is accelerating due to an increased focus on preventing needle-stick injuries and hospital-acquired infections (HAIs).

Asia-Pacific is growing at the fastest pace in the IV cannula market

Several countries in the APAC region, such as India, China, and Southeast Asia, are experiencing rapid growth in their healthcare infrastructure. Governments and private sectors are investing in medical facilities, hospitals, and clinics to meet the needs of a growing and aging population, which directly contributes to the demand for medical devices, including IV cannulas.

For instance, the Indian government has introduced initiatives like the Ayushman Bharat program, which aims to provide healthcare access to over 500 million people. This program has led to increased healthcare investments, directly boosting demand for medical devices such as IV cannulas.

The rise in medical tourism in countries such as India, Thailand, and Singapore contributing to the demand for advanced medical devices like IV cannulas. Medical tourists often seek affordable and high-quality medical treatments, including surgeries, which require intravenous therapies, driving the market for IV cannulas. For instance, India is one of the world's top destinations for medical tourism, with over 5 million medical tourists visiting annually for treatments like cardiac surgery, orthopedic surgeries, and cosmetic surgeries, all of which require intravenous access.

Competitive Landscape

The major global players in the IV cannula market include Becton, Dickinson and Company, Nipro Corporation, Romsons Scientific & Surgical Pvt. Ltd., Medtronic plc, Cruzine, MRK Healthcare Pvt. Ltd., Bio Med Healthcare Products Pvt Ltd, AdvaCare Pharma, iLife Medical Devices Pvt Ltd, Neotec Medical and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global IV cannula market report delivers a detailed analysis with 78 key tables, more than 83 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Gauge Size
  • 2.5. Snippet by Material
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Number of Surgical Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Infections and Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. IV Cannula Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Peripheral IV Cannula*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Central IV Cannula
  • 5.4. Draining Cannulas

6. IV Cannula Market, By Gauge Size

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 6.1.2. Market Attractiveness Index, By Gauge Size
  • 6.2. 14G*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. 16G
  • 6.4. 17G
  • 6.5. 18G
  • 6.6. 20G
  • 6.7. 22G
  • 6.8. 24G
  • 6.9. 26G

7. IV Cannula Market, By Material

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 7.1.2. Market Attractiveness Index, By Material
  • 7.2. Polyurethane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Teflon (Polytetrafluoroethylene (PTFE))
  • 7.4. Silicone
  • 7.5. PVC (Polyvinyl Chloride)
  • 7.6. Others

8. IV Cannula Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Blood Transfusion*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Drug Administration
  • 8.4. Surgical Procedures
  • 8.5. Diagnostic Procedures
  • 8.6. Others

9. IV Cannula Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Homecare Settings
  • 9.5. Others

10. IV Cannula Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Gauge Size
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. Becton, Dickinson and Company*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Nipro Corporation
  • 12.3. Romsons Scientific & Surgical Pvt. Ltd.
  • 12.4. Medtronic plc
  • 12.5. Cruzine
  • 12.6. MRK Healthcare Pvt. Ltd.
  • 12.7. Bio Med Healthcare Products Pvt Ltd
  • 12.8. AdvaCare Pharma
  • 12.9. iLife Medical Devices Pvt Ltd
  • 12.10. Neotec Medical

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us